For the duration of incarceration and after release, treatment of PD can increase cART adherence (Blower et al. [2000]), and reduce sexual risk behavior (Kalichman [2008]).
To determine whether short-coursetreatment of latent tuberculosis infection (LTBI) with 2 months of rifampin and pyrazinamide (2RZ) is well tolerated and leads toincreased treatment completion among jail inmates, a group who maybenefit from targeted testing and treatment for LTBI but for whomcompletion of ≥ 6 months of isoniazid treatment is difficult becauseof the short duration of incarceration.
The first is that duration of incarceration does not decrease recidivism.
The researchers aimed to see if their duration of incarceration was linked to general health, functional limitations, depressive symptoms and suicidal thoughts as adults.
And third, no county, state or national prison system has ever decreased crime by using mandatory minimums or increasing the duration of incarceration of its offenders.
The median duration of incarceration at the facility was 34 days.
The median duration of incarceration was 28 days; among the 323 subjects approached, 90 (28%) were no longer incarcerated after 7 days, 118 (37%) after 14 days, and 247 (76%) at 90 days after admission.
Duration of incarceration ranged from 1 day to the entire length of follow-up (12 years and 3 months), with a median duration of 71 days.
Taken together, the low prevalence of TB among individuals who were new to the prison system and the association between the duration of incarceration and LTBI positivity imply that prisons are critical to TB transmission.
Moreover, duration of incarceration was associated with TST positivity, controlling for other demographic risk factors, which further implicates prisons as the source of tuberculosis infection rather than high-risk characteristics of the inmate population.
